Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions
How to Cite
OrthoEvidence. Zoledronic Acid for Nonmalignant Painful Bone Marrow Lesions. ACE Report. 2022;231(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14583
Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial (ZoMARS)J Bone Miner Res. 2022 Mar;37(3): 420-427.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
48 patients with painful bone marrow lesions were randomized to receive Vitamin D and calcium supplementation plus a single dose of intravenous Zoledronic acid (n=34) or placebo (n=14). The primary outcome of interest was the change in volume/size of the lesion. Secondary outcomes of interest included pain on a Visual Analog Scale (VAS), pain disability index (PDI), bone-specific quality of life q...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE